# Comprehensive Analysis of Immune-Related Mitochondrial Genes in Ischemic Stroke Through Integrated Bioinformatics and Validation

**Authors:** Chenchen Li, Runfa You, Xianghua Meng, Haowen Long, Chao Zheng, Zijie Zhan

PMC · DOI: 10.3390/biomedicines14020375 · Biomedicines · 2026-02-05

## TL;DR

This study identifies immune-related mitochondrial genes linked to ischemic stroke, offering new insights for diagnosis and treatment.

## Contribution

The study introduces five novel immune-related mitochondrial biomarkers with strong diagnostic potential for ischemic stroke.

## Key findings

- Five key genes (ECHDC3, EPHX2, SPTLC2, MSRB2, and TK2) were identified as potential biomarkers for ischemic stroke.
- Three genes (ECHDC3, EPHX2, and SPTLC2) showed strong diagnostic potential with AUC > 0.7.
- The genes are enriched in apoptosis, JAK-STAT, MAPK, and VEGF signaling pathways and linked to neutrophil infiltration.

## Abstract

Background: Ischemic stroke (IS) is a major cause of disability and mortality worldwide, with mitochondrial dysfunction playing a critical role in its pathogenesis. This study aimed to identify immune-related mitochondrial biomarkers associated with IS and evaluate their diagnostic potential. Methods: IS-related gene expression datasets were obtained from the GEO database. Differentially expressed genes (DEGs) were identified from the GSE58294 dataset, followed by functional enrichment analysis, immune infiltration assessment, and weighted gene co-expression network analysis (WGCNA). Immune-related mitochondrial genes were screened using the MITOCARTA 3.0 database. Four machine learning algorithms—random forest (RF), support vector machine (SVM), generalized linear model (GLM), and extreme gradient boosting (XGB)—were applied to identify hub genes. External validation was performed using the GSE16561 dataset, and RT-qPCR confirmed key gene expression. Functional enrichment and single-cell RNA sequencing analyses explored biological pathways and cellular localization. Results: Five key genes (ECHDC3, EPHX2, SPTLC2, MSRB2, and TK2) were identified, among which ECHDC3, EPHX2, and SPTLC2 showed strong diagnostic potential (AUC > 0.7). These genes were significantly enriched in apoptosis, JAK-STAT, MAPK, and VEGF signaling pathways and were closely associated with neutrophil infiltration. Single-cell analysis revealed increased immune cell populations and distinct expression patterns of key genes in the ischemic mouse brain. Conclusions: This study identifies novel immune-related mitochondrial biomarkers for IS, providing insights into its pathogenesis and offering potential targets for early diagnosis and therapeutic intervention.

## Linked entities

- **Genes:** ECHDC3 (enoyl-CoA hydratase domain containing 3) [NCBI Gene 79746], EPHX2 (epoxide hydrolase 2) [NCBI Gene 2053], SPTLC2 (serine palmitoyltransferase long chain base subunit 2) [NCBI Gene 9517], MSRB2 (methionine sulfoxide reductase B2) [NCBI Gene 22921], TK2 (thymidine kinase 2) [NCBI Gene 7084]
- **Diseases:** ischemic stroke (MONDO:1060198)

## Full-text entities

- **Genes:** S100a8 (S100 calcium binding protein A8 (calgranulin A)) [NCBI Gene 20201] {aka 60B8Ag, B8Ag, CFAg, CP-10, Caga, MRP8}, Mrpl41 (mitochondrial ribosomal protein L41) [NCBI Gene 107733] {aka MRP-L27, Rpml27}, Msrb2 (methionine sulfoxide reductase B2) [NCBI Gene 76467] {aka 2310050L06Rik, Mrsb, Msrb, Pilb}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, SHROOM4 (shroom family member 4) [NCBI Gene 57477] {aka MRXSSDS, SHAP, shrm4}, MRPL41 (mitochondrial ribosomal protein L41) [NCBI Gene 64975] {aka BMRP, MRP-L27, MRPL27, PIG3, RPML27, mL41}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, EPHX2 (epoxide hydrolase 2) [NCBI Gene 2053] {aka ABHD20, CEH, SEH}, PSAP (prosaposin) [NCBI Gene 5660] {aka GLBA, PARK24, PSAPD, SAP1, SAP2}, Sptlc2 (serine palmitoyltransferase, long chain base subunit 2) [NCBI Gene 20773] {aka LCB2, LCB2a, Spt2}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, ECHDC3 (enoyl-CoA hydratase domain containing 3) [NCBI Gene 79746], Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Ephx2 (epoxide hydrolase 2, cytoplasmic) [NCBI Gene 13850] {aka CEH, Eph2, SEH, sEP}, CRYGEP (crystallin gamma E, pseudogene) [NCBI Gene 200575] {aka CCL, CRYG5, CRYGEP1, D2S1472, G2}, CYB5R3 (cytochrome b5 reductase 3) [NCBI Gene 1727] {aka B5R, DIA1}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, MSRB2 (methionine sulfoxide reductase B2) [NCBI Gene 22921] {aka CBS-1, CBS1, CGI-131, MSRB, PILB}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, DCK (deoxycytidine kinase) [NCBI Gene 1633], PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, CCDC127 (coiled-coil domain containing 127) [NCBI Gene 133957], Echdc3 (enoyl Coenzyme A hydratase domain containing 3) [NCBI Gene 67856] {aka 2310005D12Rik}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, SPTLC2 (serine palmitoyltransferase long chain base subunit 2) [NCBI Gene 9517] {aka HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TK2 (thymidine kinase 2) [NCBI Gene 7084] {aka MTDPS2, MTTK, PEOB3, SCA31, TK2-EXT}, CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, MOCS1 (molybdenum cofactor synthesis 1) [NCBI Gene 4337] {aka MIG11, MOCOD, MOCS1A, MOCS1B}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, Tk2 (thymidine kinase 2, mitochondrial) [NCBI Gene 57813] {aka mt-TK}
- **Diseases:** Neuronal damage (MESH:D009410), hypoxic (MESH:D002534), bleeding (MESH:D006470), mitochondrial DNA depletion (MESH:C536350), Stroke (MESH:D020521), ischemia (MESH:D007511), UMAP (MESH:C567162), brain tissue damage (MESH:D017695), injury to (MESH:D014947), inflammation (MESH:D007249), IR (MESH:D015427), hypertension (MESH:D006973), arterial occlusion (MESH:D001157), neurological damage (MESH:D020196), death (MESH:D003643), acute coronary syndrome (MESH:D054058), Mitochondrial dysfunction (MESH:D028361), MCAO (MESH:D020244), Ischemic injury (MESH:D017202), brain ischemia (MESH:D002545), plaque (MESH:D003773), Cerebral infarction (MESH:D002544), tumor (MESH:D009369), cardioembolic stroke (MESH:D000083262), neuroinflammation (MESH:D000090862)
- **Chemicals:** water (MESH:D014867), ATP (MESH:D000255), chloroform (MESH:D002725), lipid (MESH:D008055), isoflurane (MESH:D007530), TRIzol (MESH:C411644), Sphingolipids (MESH:D013107), isopropanol (MESH:D019840), epoxides (MESH:D004852), ethanol (MESH:D000431), ceramide (MESH:D002518), calcium (MESH:D002118), ROS (MESH:D017382), anticancer (-), silicon (MESH:D012825), MetO (MESH:D008715), nylon (MESH:D009757), unsaturated fatty acids (MESH:D005231), oxygen (MESH:D010100), thymidine monophosphate (MESH:D013938), fatty acid (MESH:D005227)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** K55R, G860A
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938822/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938822/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938822/full.md

---
Source: https://tomesphere.com/paper/PMC12938822